Integrated Filing — IndAS

General information about company
Scrip Code	500830
NSE Symbol	COLPAL
MSEI Symbol	NOTLISTED
ISIN	INE259A01022
Name of company	Colgate Palmolive (India) Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	21-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	05-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	PERSONAL CARE Including Oral Care
Start date and time of board meeting	21-May-2025   15:00:00
End date and time of board meeting	21-May-2025   16:30:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-05-21
Indicate Company website link for updated RPT policy of the Company	chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.colgateinvestors.co.in/media/1063/related-party-transactions-policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	14625100000	60401700000
	Other income	190600000	1388400000
	Total income	14815700000	61790100000
2	Expenses
(a)	Cost of materials consumed	3864700000	15791100000
(b)	Purchases of stock-in-trade	653100000	3098600000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-220100000	-707000000
(d)	Employee benefit expense	1072700000	4467800000
(e)	Finance costs	10800000	43200000
(f)	Depreciation, depletion and amortisation expense	383700000	1627400000
(f)	Other Expenses
1	Advertising	1805700000	8224600000
2	Others	2468900000	9946000000
	Total other expenses	4274600000	18170600000
	Total expenses	10039500000	42491700000
3	Total profit before exceptional items and tax	4776200000	19298400000
4	Exceptional items	0	0
5	Total profit before tax	4776200000	19298400000
6	Tax expense
7	Current tax	1307200000	4949300000
8	Deferred tax	-81000000	-19000000
9	Total tax expenses	1226200000	4930300000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	3550000000	14368100000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	3550000000	14368100000
17	Other comprehensive income net of taxes	-38200000	-38200000
18	Total Comprehensive Income for the period	3511800000	14329900000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	272000000	272000000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		0
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	13.05	52.83
	Diluted earnings (loss) per share from continuing operations	13.05	52.83
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	13.05	52.83
	Diluted earnings (loss) per share from continuing and discontinued operations	13.05	52.83
24	Debt equity ratio	0	0
25	Debt service coverage ratio	0	0
26	Interest service coverage ratio	0	0
27	Disclosure of notes on financial results		1 Debt relates to Lease Liabilities only The Company does not have any debts borrowings. n n Debt Equity Ratio as per schedule III n n Debt Equity Ratio Total Debt/Shareholder's Equity 0.04 n n2 Debt Service Coverage Ratio Earnings available for Debt ServiceDebt Service 91.55 n n3 Interest Service Coverage Ratio EBIT Interest 431.92 n n Interest cost on leases which are part of Lease Liabilties in the Financial Statements as per IndAS 116 n adoption is disclosed as Finance Cost in the results. The Company does not have any debts borrowings

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	7764600000
	Capital work-in-progress	384100000
	Investment property	0
	Goodwill	0
	Other intangible assets	0
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current	0
	Loans, non-current	12000000
	Other non-current financial assets	178300000
	Total non-current financial assets	190300000
	Deferred tax assets (net)	679500000
	Other non-current assets	89700000
	Total non-current assets	9108200000
2	Current assets
	Inventories	3772600000
	Current financial asset
	Current investments	0
	Trade receivables, current	2262500000
	Cash and cash equivalents	6681000000
	Bank balance other than cash and cash equivalents	4270300000
	Loans, current	66700000
	Other current financial assets	64800000
	Total current financial assets	13345300000
	Current tax assets (net)	3450200000
	Other current assets	509200000
	Total current assets	21077300000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	30185500000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	272000000
	Other equity	16372700000
	Total equity attributable to owners of parent	16644700000
	Non controlling interest
	Total equity	16644700000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	467300000
	Total non-current financial liabilities	467300000
	Provisions, non-current	299100000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	3000000
	Total non-current liabilities	769400000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	93100000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	9114800000
	Total Trade payable	9207900000
	Other current financial liabilities	623400000
	Total current financial liabilities	9831300000
	Other current liabilities	1355000000
	Provisions, current	1015500000
	Current tax liabilities (Net)	569600000
	Deferred government grants, Current	0
	Total current liabilities	12771400000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	13540800000
	Total equity and liabilites	30185500000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments	Textual Information(2)

Text Block
Textual Information(2)	The Company has identified Personal Care including Oral care as its only primary reportable segment in accordance with the requirements of Ind AS 108 Operating Segments .Accordingly no seperate segment information has been provided.

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurement gains/ (losses) on defined benefit plans	-51100000	-51100000
	Total Amount of items that will not be reclassified to profit and loss	-51100000	-51100000
2	Income tax relating to items that will not be reclassified to profit or loss	-12900000	-12900000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-38200000	-38200000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			19298400000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			43200000
	Adjustments for decrease (increase) in inventories			-808500000
	Adjustments for decrease (increase) in trade receivables, current			-644400000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			34000000
	Adjustments for decrease (increase) in other non-current assets			-10400000
	Adjustments for other financial assets, non-current			-38500000
	Adjustments for other financial assets, current			-4700000
	Adjustments for other bank balances			24900000
	Adjustments for increase (decrease) in trade payables, current			388900000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			96700000
	Adjustments for increase (decrease) in other non-current liabilities			-600000
	Adjustments for depreciation and amortisation expense			1627400000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			29200000
	Adjustments for provisions, non-current			134100000
	Adjustments for other financial liabilities, current			-15500000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-21500000
	Adjustments for dividend income			0
	Adjustments for interest income			24900000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			-543600000
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			265800000
	Net cash flows from (used in) operations			19564200000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			5619600000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			13944600000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			300000
	Purchase of property, plant and equipment			714200000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			698800000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			574800000
	Net cash flows from (used in) investing activities	559700000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			-276100000
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			0
	Payments of lease liabilities			175000000
	Dividends paid			16262100000
	Interest paid			0
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-16713200000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-2208900000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-2208900000
	Cash and cash equivalents cash flow statement at beginning of period			8889900000
	Cash and cash equivalents cash flow statement at end of period			6681000000